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Rotavirus is the major cause of severe dehydrating diarrhoea in young children worldwide.
Considerable research has been carried out on rotavirus disease in India. This review collated
data from 46 epidemiological studies to determine rotavirus positivity rates and genotypes of
infecting rotavirus strains from various settings in India. Studies on diarrhoea presenting to
hospitals, neonatal rotavirus infections, symptomatic and asymptomatic infections in the community
and nosocomial enteric infections were included. Rotavirus positivity rates varied greatly between
different settings - diarrhoea hospitalizations (20%), neonatal infections (35%), symptomatic and
asymptomatic infections in the community (15.1% and 6.3% respectively) and nosocomial enteric
infections (22.5%). Among diarrhea hospitalizations, the commonest G types were G1 and G2
while commonest P types were P[8], P[6] and P[4]. Region specific neonatal infections by bovine-
human reassortants have been reported, in addition to several recently described unusual strains,
which may be evidence of zoonotic infection and/or reassortment. The emergence of several new
strains highlights the need for intensive strain surveillance before and after the introduction of a
new vaccine.
Key words Genotyping - India - rotavirus
Rotaviruses are the major cause of severe
gastroenteritis in infants and young children
worldwide. Since the first description in humans in
1973, and their subsequent recognition as a major
human pathogen, there have been a large number of
studies on the structure, pathogenesis and
epidemiology of these viruses. Their clinical
relevance, structural complexity and unique
morphogenesis strategies have prompted extensive
research on these viruses in recent years, using
molecular biological techniques1.
It is estimated that rotavirus is responsible for
611,000 deaths annually with 80 per cent of these
taking place in poorer countries2. Vaccines offer the
most promising tool for preventing morbidity and
mortality caused by rotavirus. The first licensed
rotavirus vaccine was withdrawn due to a temporal
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association with intussusception3. Efforts to develop
new, safer vaccines are now underway with two
vaccines having been licensed in Mexico and the
United States after extensive safety trials4. Testing
of candidate vaccines derived from two rotavirus
strains which caused asymptomatic infections in
neonates in India are also being carried out. The
potential availability of rotavirus vaccines in the near
future, including recently licensed vaccines from
Merck and Glaxo SmithKline5,6 as well as vaccines
currently in development in India highlights the need
to better define the epidemiology and disease burden
associated with rotavirus. The epidemiological
profile of these viruses in India will  be of
considerable importance to both policy makers and
vaccine developers in determining the composition,
dosage and schedule for a vaccine to be used in India.
Structure and classification
Rotaviruses are double stranded RNA viruses
comprising a genus within the family Reoviridae.
The mature virus particles are triple layered,
approximately 70 nm in diameter, and possess
icosahedral symmetry. The rotavirus genome consists
of 11 segments of double-stranded RNA, that code
for 6 structural viral proteins (VP1, VP2, VP3, VP4,
VP6 and VP7) and 6 non-structural proteins (NSP1 -
NSP6)7, with gene segment 11 encoding both NSP5
and 6. The genome is encompassed by an inner core
consisting of VP2 with small amounts of VP1 and
VP3 proteins. The intermediate layer or inner capsid
is made of VP6, which determines group and
subgrouping specificities. The outer capsid layer is
composed of two proteins, VP7 and VP4 that elicit
neutralizing antibody responses (Fig. 1).
Rotaviruses are classified by a scheme of groups
and multiple serotypes/genotypes within each group.
The classification of rotavirus into seven different
groups (A-G) is based on the antigenic specificity of
the VP6 capsid proteins, as well as on the pattern of
electrophoretic mobility of the 11 RNA segments of
the viral genome. Of the seven groups, only groups
A, B and C are known to infect humans. Severe, life-
threatening disease in children worldwide is caused
predominantly by group A rotaviruses. Within group
A, four different subgroups (SG); SGI, SGII, SGI
and II, and nonI/nonII, have been distinguished on
the basis of VP6 diversity, of which human strains
are possibly only from SGI or SGII8.
Further typing schemes to describe rotavirus
strains are based on the proteins of the outer capsid
that elicit neutralizing antibodies- VP7 (G serotypes)
and VP4 (P serotypes). G- and P- serotypes were
defined based on their reactivity to specific
monoclonal antibodies (MAbs). While the use of
MAbs for VP7 was relatively easy, cross reactivity
between serotypes precluded use of MAbs for VP4
serotyping. Variability in the genes encoding the two
outer capsid proteins VP7 and VP4 form the basis of
the current strain typing of group A rotaviruses into
G and P genotypes respectively. All known G
serotypes correspond with genotypes; more P
genotypes than serotypes have been identified.
Currently, a rotavirus strain is identified by a G
genotype, indicated by a number, followed by its P
type. To distinguish strains identified by P
genotyping from those identified by P serotyping,
the dual serotype/genotype nomenclature is used. P
genotypes are expressed as P followed by a number
in square brackets whereas P serotypes are designated
as P with serotype number, followed by
corresponding genotype in square brackets (e.g., the
same strain could be represented as G9P[6], when
both G and P genotypes are used, or G9P2A[6] when
G genotype is followed by P serotype/genotype
classification). At least 15 G genotypes and 25 P
genotypes have been identified to date9.
Rotavirus detection and strain characterization
Laboratory procedures for diagnosis of rotavirus
include electron microscopy (EM), passive latex
agglutination assays (LA), electropherotyping using
polyacylamide gel electrophoresis (PAGE), enzyme-
linked immunosorbent assays (ELISA) and reverse
transcription - polymerase chain reaction (RT-
PCR)10. In recent years, ELISA has become the
method of choice for screening. The sensitivity of
routine diagnostics is high since the amount of virus
excreted by a child with rotavirus diarrhoea (~1010
viruses/g of stool) far exceeds the level of detection
(~107 viruses/g of stool)11.
Early studies on strain surveillance identified
rotavirus serotypes using neutralization assays.
Monoclonal antibodies to specific serotypes were
used. New methods have greatly improved data on
circulating rotavirus strains and include multiplex
RT-PCR based genotyping, hybridization assays and
nucleotide sequencing.
The rapid evolution of rotaviruses by a variety of
mechanisms provides one of the major challenges in
epidemiological studies. Interspecies transmission
plays an important role in the diversity of rotaviruses.
The ability of rotaviruses to reassort during co-
infections results in the exchange of genetic material
between human and animal viruses and generates
novel viruses. Different mechanisms have been used
to describe the evolution of rotaviruses. These include
genetic drift, wherein accumulation of point mutations
generates genetic lineages leading to the emergence
of antibody escape mutants, and genetic shift through
gene reassortment during dual infection of a single
cell12. Hence methods of virus typing need to be
regularly monitored and updated to identify emerging
novel strains of epidemiological importance.
Rotavirus epidemiology in India
Considerable research has been carried out on
rotavirus disease in India in different settings.
Collation of data from these studies is frequently not
possible due to the differences in study design,
populations examined, and the testing methodologies
used. The studies have, however, documented the
marked diversity of rotavirus strains circulating in
India, as well as the prevalence of unusual strains.
Since the introduction and wider use of molecular
biology-based typing methods, strains with G and P
genotypes other than those considered common have
increasingly been reported. G1, G2 and G4 strains
are seen in almost all parts of the country, while there
are few reports on G3 strains. In the past 5 years,
four VP7 (G6, G8, G10 and G12) and one VP4
genotype (P[19]) have been newly identified as
causes of diarrhoea in humans13.
A review in 2001 presented data from studies
published from India on rotaviral disease14, but provided
only the limited genotyping information available at
the time. A review published in 2003 described the
distribution of rotavirus in various settings in India
published till 200215, but does not include a number of
very recent publications describing unusual strains,
particularly those that are potentially zoonotic in origin.
In this review, we included studies published from 1990
to 2005 to collate data on the molecular epidemiology
of rotaviruses in India. The studies were categorized as
(i) rotavirus diarrhoea presenting to hospitals, (ii)
neonatal rotavirus infections, (iii) rotavirus infection
in the community, and (iv) nosocomial rotavirus
infections. Studies in each group were then grouped by
city for analysis.
For data on neonatal rotavirus infections and
hospitalization due to rotavirus infection, studies
published from 1990 to the present time were
included. Since limited data are available on rotavirus
in the community, all papers published on community
rotavirus infections were included. For data on
burden of rotavirus disease, all studies were included
irrespective of detection technique used. To
determine the G and P types circulating in India, only
studies that used serotyping, hybridization assays or
RT-PCR for G and P characterization of strains were
included. Characterization data from studies using
electropherotyping were not included, if it was not
possible to also obtain data on G and P types from
the studies.
Rotavirus diarrhoea in children hospitalized with
acute gastroenteritis
A total of 29 studies carried out using samples
obtained from children presenting with diarrhoea to
a health care facility were included.
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Rotavirus disease in hospitalized children: Data from
22 Indian cities are shown in Table I16-43. A total of
15,476 samples have been tested. Rates of rotavirus
positivity ranged from 6 to 45 per cent (median
20.8%). The studies were carried out in various
geographic locations in India. Most studies used
ELISA and/or PAGE for the screening of rotavirus
although latex agglutination assay, immunoblot and
electron microscopy were also used in a limited
number of studies.
Data from a study on the burden of infectious
diseases in South Asia published in 2004 showed that
an estimated 576,480 deaths occur due to diarrhoea
in children in India44. Applying the above figure of
20.8 per cent of all diarrhoeas to be caused by
rotavirus, it can be estimated that rotavirus is
responsible for approximately 119,908 deaths
annually. There are no published prospective studies
that have examined rates of diarrhoea and
hospitalizations in India. However, recent data from
a birth cohort of 452 children in Vellore have shown
that, in infancy rates of diarrhoeal episodes/child year
(95% CI) is 3.6 (3.3 - 3.9), with a hospitalization
rate/100 child years (95% CI) of 5.8 (3.8 - 8.8).
Diarrhoea was the second most common cause for
both outpatient visits and hospitalization after
respiratory infections (unpublished data).
Rotavirus  typing of  s trains  obtained from
hospitalized children: G- and P- typing was carried
out using MAbs, genotyping primers or probes. A
total of 1998 and 1108 samples were G- and P-
typed respectively. The overall distribution of G
and P types is shown in Figs 1 and 2. While most
centres used MAbs or primers specific to G1- G4
and G9 types; G6, G8 and G10 were also included
in some places.  G1 and G2 were the most prevalent
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Fig. 1. Structure of rotavirus. Coding assignments of 11 RNA segment (left) and schematic diagram of ratavirus (right).
Table I. Burden of rotavirus disease in hospitalized children
Centre Year of study Age (yr) Testing method Samples
Tested Positive
n n %
North India:
Chandigarh16 1982 - 1985 <5 ELISA 694 111 15.9
Delhi17 1987 - 1989 <5 ELISA 978 176 18.0
Delhi18 1987 - 1988 <5 ELISA 288 44 15.3
Delhi19 1988 - 1990 <5 ELISA 990 104 10.5
Delhi20 1989 - 1990 <3 Immunodot 400 23 6.0
Delhi21 1990 - 1991 <5 ELISA/PAGE 450 60 13.3
Delhi22 1990 <5 ELISA 157 71 45.0
Delhi23 1998 - 2000 <5 ELISA/PAGE 1172 158 13.5
Delhi24 2000 - 2001 <5 ELISA 584 137 23.5
Delhi25 1998 - 2000 <3 ELISA/PAGE 560 100 17.8
North India26 NK NK ELISA 172 32 19.0
Western India:
Bombay27 1984 - 1986 NK LA /EM / ELISA 273 63 21.0
Pune28 1990 - 1993 children ELISA 722 188 26.0
Pune29 1992 - 1996 <5 ELISA 945 266 28.2
Eastern India:
Dibrugarh30 1999 - 2000 <5 ELISA 202 47 23.3
South India:
Bangalore31 1988 - 1994 NK PAGE 694 150 21.6
Chennai32 1997 - 1999 0 - 2, >2 ELISA 245 51 20.8
Chennai33 1995 - 1999 <3 ELISA 745 168 22.6
Hyderabad34 1998 - 1999 <2 PAGE 352 57 16.2
Manipal35 NK <5 LA 106 19 18
Mysore31 1993 - 1994 NK PAGE 447 50 11.2
Tirupati36 1991 <2 ELISA 170 40 23.5
Vellore37 1995 - 1998 <5 ELISA / LA 602 126 20.9
Vellore38 2002 - 2004 <5 ELISA/ LA 343 94 27.1
Multiple**:
Multiple 139 1993 6m to <5 ELISA 458 63 13.7
Multiple 240 1996 - 1998 <5 ELISA 1502 313 20.8
Multiple 341 1998 - 1999 <5 LA /EM / ELISA 365 82 22.5
Multiple 442@ 1998 - 2000 <4 PAGE 406 141 34.7
Multiple 543# 2001 <4/all# PAGE 454 161 35.4
Total 15476      3095
NK, not known
<4/all#:  Samples collected from two groups: children <4 yr, patients of all age groups
LA, latex agglutination; EM, electron microscopy; PAGE, polyacrylamide gel electrophoresis; ELISA, enzyme linked immunosorbent
assay. ** Multiple studies in which samples were collected from more than one city.
Multiple 1: Shimla, Lucknow, Bhopal, Nagpur, Davengere
Multiple 2: Shimla, Lucknow, Bhopal, Nagpur, Davengere, Delhi, Hyderabad
Multiple 3: Vellore, Mysore, Jalandhar, Yamunagar
Multiple 4: Kolkata, Imphal, @ Data on disease burden from Kolkata only
Multiple 5: Kolkata, Dibrugarh, Bhuvaneshwar, Chandigarh
RAMANI & KANG: ROTAVIRUS IN INDIA 623
(24.7 and 23.4% respectively). However, the
overall strain distribution varied from one location
to another (Table II, Fig. 2). The commonest P type
was P[8] (27%) followed by P[6] (21%) and P[4]
(20%) (Table III, Fig. 3).
Unusual strains of rotavirus: A number of unusual
strains of rotavirus have been reported in the recent
years. Characterization of strains that remained
untypable by routine typing methods have resulted
in the identification of these unusual strains
including G6 strains from Pune46, G8 strains from
Vellore 37 and Mysore 47,  G12 f rom Calcut ta
(Kolkata)48, G3P[8] from western India49, G9P[19]
strains from Manipur50 and G10P[11] strains from
Vellore10. Most of these strains are of possible
animal origin or animal-human reassortants,
containing one or more genes that are highly
ident ical  to  corresponding genes  in  animal
rotaviruses.
The G6 genotype described from Pune showed
>94 per cent identity of VP7 gene with bovine
rotavirus RF isolated from France46.  The G8
genotype described from Vellore and Mysore
showed about 95 per cent similarity in the amino
acid sequence of VP7 gene to bovine strain A537,47.
The G3P[8] genotype described among tribals in
western India showed 100 per cent identity of VP7
gene to simian rotaviruses and 99 per cent identity
to human P[8]49. The G9P[19] genotype from
Manipur appeared to be a porcine -  human
reassortant with human VP7 and VP4, VP6 and
NSP4 closely related to porcine rotaviruses50.
G10P[11] strains described from Vellore appear to
be bovine human reassortants with all genes of
bovine origin except NSP1 and NSP3 (unpublished
data).
Comparison of rotavirus diarrhoea among
outpatients and hospitalized patients
One study carried out between 1993 and 1996
in Pune was reviewed51. A total of 489 and 628
faecal samples were collected from inpatient and
outpatient  children <5 yr with diarrhoea
respectively. The rate of rotavirus detection was
higher among in-patients (28.3%) than outpatients
(15.5%).
Neonatal rotavirus infections
Studies have reported the association of
asymptomatic rotavirus infections in neonates with
specific strains. The neonatal rotavirus strain is
characterized by its endemicity and persistence in
the neonatal ward. Maternal antibodies and
Fig. 3. Overall distribution of P types in India (studies from
1990-2004). [Source:  Table III].
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Fig. 2. Overall distribution of G types in India (studies from
1990-2004). [Source:  Table II].
Mixed
Untypable
P11
P8
P6
P4
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Table II. Distribution of G types in various geographic locations in India
Centre Year of study Age (yr) No. tested G1 G2 G3 G4 G9 Mixed UT
North India:
Delhi21 1990 - 1991 <5 51 17 13 5 4  — 5 7
Delhi25 1998 - 2000 <3 100 31 12 18 5  — — 34
Delhi24 2000 - 2001 <5 135 32 18 8 — 21 10 46
Western India:
Pune28 1990 - 1993 children 205 15 49 1 9 — 33 98
Eastern  India:
Calcutta45 1999 - 2000 NK 150 49 27 — 30 — 18 16
South India:
Bangalore31 1988 - 1994 NK 150 15 20 53 7 — — 55
Chennai32 1997 - 1999 0 - 2, >2 48 7 33 1 — — 7 —
Chennai33 1995 - 1999 <3 118 11 78 2 16  — 11 —
Hyderabad34 1998 - 1999 <2 46 16 — — 8 — 5 17
Mysore31 1993 - 1994 NK 50 23 — 12 — — — 15
Vellore37 1995 - 1998 <5 126 50 24 1 30 5 10 25
Vellore38 2002 - 2004 <5 94 44 8 — — 18 4 19
Multiple:
Multiple 139 1993 6 m to <5 63 7 14 7 6 15 7 7
Multiple 240 1996 - 1998 <5 287 51 99 2 32 50 31 22
Multiple 341 1998 - 1999 <5 82 33 7 9 12 7 — 14
Multiple 442 1998 - 2000 <4 159 61 38 — 20 — 11 29
Multiple 543 2001 <4/all 126 62 17 — 6  — 26 15
Total 1998 524 457 119 185 116 178 419
*UT, untypable; NK, not known
Table III. Distribution of P types in various geographic locations in India
Centre Year of study Age (yr) No. tested P[4] P[6] P[8] P[11] Mixed UT
Delhi21 1990 - 1991 <5 57 14 4 23 — 3 14
Delhi24 2000 - 2001 <5 135 16 29 32 1 7 50
Multiple 139 1993 6m to <5 63 13 27 8 — 7 7
Multiple 240 1996 - 1998 <5 287 63 88 69 10 33 24
Multiple 341 1998 - 1999 <5 82 19 2 31 — — 30
Multiple 442 1998 - 2000 <4 138 35 8 51 — 26 19
Multiple 543 2001 <4/all 126 19 61 — — 19 27
Vellore37 1995 - 1998 <5 126 32 7 39 — — 48
Vellore38 2002 - 2004 <5 94 5 2 52 2 — 32
1108 216 228 305 13 95 251
*UT, untypable
physiologic immaturity of the neonatal gut may play
a role in majority of neonatal infections being
asymptomatic52. Neonatal rotavirus infections are
believed to confer protection against subsequent
infection and disease. Hence candidate vaccine
strains have been derived from strains circulating in
neonatal nurseries including two vaccine candidates
currently in development in India53. However,
symptomatic neonatal infections associated with
necrotizing enterocolitis, acute gastroenteritis and
feed intolerance have also been reported10.
Studies on neonatal rotavirus infections
published before 1990 were reviewed in 200114.
Subsequent studies using RT-PCR and genotyping
of neonatal rotavirus strains have shown region
specific asymptomatic infections by unusual strains
(Table IV). This includes G9P[11] in Delhi54 and
G10P[11] in Bangalore and Mysore55.  Both
symptomatic and asymptomatic infections by
G10P[11] strain have been reported in Vellore10. Both
neonatal strains appear to be bovine-human
reassortants. G9P[11] is a human strain with a bovine
VP4 while G10P[11] is composed mainly of bovine
genes and has gene segments 5 and 7, encoding NSP1
and 3, of human origin53.
Rotavirus infection in the community
Community based studies provide geographically
representative information on the disease burden,
strain prevalence and rates of rotavirus infection in
the community. This is of considerable significance
in understanding the natural course of infection and
for comparison of symptomatic and asymptomatic
infections.
Since no data on rotavirus infection in the
community in India have been reviewed so far, all
studies have been included. It must be noted that all
studies except one from Vellore have been carried
out around or before 1990, and hence may not
represent the most recent scenario of community
rotavirus infections. The studies have been carried
out in various settings: rural, semi-urban and urban.
All except one study have used ELISA for detection
of rotavirus. The studies from four centres include
samples from both symptomatic and asymptomatic
infections while data from two centres are based only
on symptomatic infections in the community (Table
V). Rotavirus positivity rate ranges from 4 to 29.3
per cent in symptomatic cases and 2.4 to 12.3 per
cent in asymptomatic cases.
Nosocomial rotavirus infections
Nosocomial enteric infections are defined as
those occurring more than 72 h after admission to
hospital for non diarrhoeal causes or shortly after
discharge. Nosocomial rotavirus infection among
children results in a significant economic burden,
both by prolonging the hospitalization of the affected
child and by also serving as a reservoir that
propagates additional cases of rotavirus infection.
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Table IV. Neonatal rotavirus infections in India
Centre Year Symptoms Screening No. Predominant strain
Tested Positive
n n %
Delhi54 1993 Asymptomatic ELISA 169 38 33 G9P[11]
PAGE
Bangalore55 1988 - 1997 Asymptomatic ELISA 882 321 39 G10P[11]
Vellore10 1999 - 2000 Symptomatic/ ELISA NK 43 NK G10P[11]
asymptomatic
NK, not known; PAGE, polyacrylamide gel electrophoresis; ELISA, enzyme linked immunosorbent assay
Three studies on nosocomial rotavirus infection
were carried out in the paediatric wards of 2 hospitals
in Calcutta (1985-1987) and one in Vellore (1990-
1991) (Table VI). A total of 3530 children were
screened for nosocomial enteric infections. The mean
nosocomial enteric infection rate was 16.16 per cent.
Of the nosocomial enteric infections, rotavirus
accounted for about 22.5 per cent of cases.
Rotavirus is recognized as the major cause of
diarrhoea hospitalizations among children in both
developed and developing countries, and it is clear
that improvements in hygiene and sanitation alone
are not sufficient to decrease or eliminate disease.
Based on studies that have shown promising results
in prevention of severe gastroenteritis with vaccine
candidates, several strains have been identified and
tested as potential vaccines. Several vaccines are
currently in various stages of development around
the world. Two vaccines from the multinational
manufacturers Merck and GlaxoSmithKline (GSK)
have completed large scale trials and have been
recently licensed. The Merck vaccine, Rotateq™ is
composed of 5 rotavirus strains. Each strain is a
single gene reassortant based on parent bovine strain
WC3, containing outer capsid gene from a human
strain. The vaccine induces immunity to G1- G4 and
P[8] genotypes. The GSK vaccine, Rotarix™ is
derived from a single human rotavirus strain G1P[8]
that was attenuated by multiple passages in cell
culture. Studies have shown both vaccines to be safe
and effective5,6.
In India, candidate vaccines have been derived
from strains causing asymptomatic infections in
neonatal nurseries. The two India neonatal candidate
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Table V. Rotavirus infection in the community
Centre Community Year of study Screening Symptoms No. Positive
Tested
n# n# %
Delhi56 Semi urban NK ELISA Symptomatic 212 45 21.2
Asymptomatic 82 2 2.4
North India57 Urban/rural 1982 - 1983 ELISA Symptomatic 150 44 29.3
Asymptomatic 350* 43 12.3
Chandigarh58 Urban/peri-urban/rural 1988 - 1991 ELISA Symptomatic 218 25 11.5
Haryana59 Rural 1985 - 1986 ELISA Symptomatic 346 14 4
Asymptomatic 211 14 6.6
Varanasi60 Urban 1988 - 1989 LA Symptomatic 17.7
Asymptomatic 4
Vellore38 Urban 2002 - 2004 ELISA Symptomatic 1152 82 7.1
NK, not known; #No. of samples; *No. of children tested positive for rotavirus; No. of samples collected per child not given LA,
latex agglutination; ELISA, enzyme linked immunosorbent assay
Table VI. Nosocomial rotavirus infections
Centre Year of study Age (yr) No. tested % Nosocomial infection no. RV Positive
No. %
Vellore61 1990 - 1991 <3 194 20.1 39 13 6.7
Calcutta62 1985 - 1986 <12 198 18.2 36 29 14.6
Calcutta63 1987 <5 3138 10.2 320 15* 8.4
*15 of 178 tested
vaccines are 116E, a G9P[11] rotavirus isolated
from neonatal nurseries in Delhi53 and I321, a
G10P[11] rotavirus described from Bangalore53.
Both strains appear to be natural bovine-human
reassortants. The vaccines are being manufactured
by Bharat Biotech in India and are in their early
phase trials.  However, the efficacy of these
vaccines has not  been tested in developing
countries, where previous rotavirus vaccine trials
have been shown to evoke a lower seroresponse and
be less effective64.
Summary
The rapid evolution of rotavirus strains and the
emergence of new strains, possibly through the
transmission of viruses across species or through
reassortment between animal and human rotaviruses,
makes it necessary to include intensive strain
surveillance of as an important component of any
vaccine implementation programme. This is
particularly important in countries such as India
where the mortality and economic burden associated
with rotavirus is high. The data on the molecular
epidemiology of rotaviruses have shown the
emergence of interesting strains that may have animal
origins. Based on VP7 type, alone G6, G8, G9, G10
and G12 strains have been newly identified in the
past few years. The questions raised by these findings
are whether this detection is because these strains
are ‘emerging’ or because more sophisticated
laboratory techniques are now being applied by
researchers in India. Even if the latter is true, the
collated data indicate that the diversity of rotaviruses
in India is greater than found in most other
developing countries, and that this will result in
challenges for vaccine efficacy that have not been
faced elsewhere.
The Cochrane Evidence Database analyses data
from 64 trials with three kinds of vaccine, bovine,
rhesus and human, and results indicate protection from
rotavirus diarrhoea of any severity65. However, the
important caveat to this update is that the majority of
the trials were carried out in developed countries where
the age of first rotavirus infection is later in childhood
and where the degree of diversity of circulating strains
is limited in comparison to developing countries.
Rotavirus vaccines generally have yielded poor
efficacy when tested in developing countries has led
to concerns about the potential effectiveness of any
future live, oral rotavirus vaccine in these settings64.
Although rotavirus infection is universal early in
childhood, the epidemiology of the disease is quite
different in developed and developing countries.
Differences in age of first infection, strain distribution,
occurrence of mixed infections, seasonality and risk
of mortality can affect decisions about vaccine
composition and delivery. Higher doses of vaccine or
additional doses may be required to overcome the
inhibitory effects of competing intestinal flora,
concomitant use of oral polio vaccine and high levels
of humorally transferred maternal antibodies against
rotavirus. Despite a recommendation by the World
Health Organization that all rotavirus vaccines be
tested early in developing countries, no data from the
current vaccines are available in Africa or poor Asian
countries. These data will be critical to determining
the probability of success of the current rotavirus
vaccines and to establish requirements for vaccines
in pre-clinical and clinical development.
In summary, rotavirus epidemiology is complex
as would be expected for a virus with multiple modes
of transmission, and this complexity is amply
illustrated in studies from India demonstrating the
diversity of the virus in different settings. The new
hope for prevention of morbidity and mortality due
to this agent is the use of oral vaccines, which are
effective in developed countries, but we need
evidence from developing countries with the highest
disease burden and virus diversity before accepting
their efficacy in all settings.
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